187 related articles for article (PubMed ID: 33482459)
1. Can antibiotic treatment failure in tubo-ovarian abscess be predictable?
Akselim B; Karaşin SS; Demirci A; Üstünyurt E
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():253-257. PubMed ID: 33482459
[TBL] [Abstract][Full Text] [Related]
2. Can the Need for Invasive Intervention in Tubo-ovarian Abscess Be Predicted? The Implication of C-reactive Protein Measurements.
Ribak R; Schonman R; Sharvit M; Schreiber H; Raviv O; Klein Z
J Minim Invasive Gynecol; 2020 Feb; 27(2):541-547. PubMed ID: 31479751
[TBL] [Abstract][Full Text] [Related]
3. Image-guided drainage management of tubo-ovarian abscess and the role of C-reactive protein measurements in monitoring treatment response: a single-center experience.
Türen Demir E; Energin H; Kilic F
Arch Gynecol Obstet; 2023 Oct; 308(4):1321-1326. PubMed ID: 37389642
[TBL] [Abstract][Full Text] [Related]
4. Impact of early surgical management on tubo-ovarian abscesses.
Zhu S; Ballard E; Khalil A; Baartz D; Amoako A; Tanaka K
J Obstet Gynaecol; 2021 Oct; 41(7):1097-1101. PubMed ID: 33249968
[TBL] [Abstract][Full Text] [Related]
5. Surgical Intervention in Patients with Tubo-Ovarian Abscess: Clinical Predictors and a Simple Risk Score.
Fouks Y; Cohen A; Shapira U; Solomon N; Almog B; Levin I
J Minim Invasive Gynecol; 2019; 26(3):535-543. PubMed ID: 29966713
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of neutrophil to lymphocyte ratio in prediction of medical treatment failure for tubo-ovarian abscess.
Alay I; Kaya C; Karaca I; Eren E; Hosgoren M; Aslanova F; Cengiz H; Ekin M; YaSar L
J Obstet Gynaecol Res; 2019 Jun; 45(6):1183-1189. PubMed ID: 30907061
[TBL] [Abstract][Full Text] [Related]
7. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study.
Kapustian V; Namazov A; Yaakov O; Volodarsky M; Anteby EY; Gemer O
Arch Gynecol Obstet; 2018 May; 297(5):1201-1204. PubMed ID: 29478102
[TBL] [Abstract][Full Text] [Related]
8. The effect of intrauterine device presence and other factors in medical treatment success of tuboovarian abscess.
Tugrul Ersak D; Ersak B; Kokanalı MK
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101983. PubMed ID: 33189945
[TBL] [Abstract][Full Text] [Related]
9. Tubo-ovarian abscess: A proposed new scoring system to guide clinical management.
Yongue G; Mollier J; Anin S; Ibeto L; Ross C; Ayim F; Guha S
Int J Gynaecol Obstet; 2022 Jun; 157(3):588-597. PubMed ID: 34534362
[TBL] [Abstract][Full Text] [Related]
10. The prediction of surgical intervention in patients with tubo-ovarian abscess.
Hwang JH; Kim BW; Kim SR; Kim JH
J Obstet Gynaecol; 2022 Jan; 42(1):97-102. PubMed ID: 33629630
[TBL] [Abstract][Full Text] [Related]
11. Operative and conservative treatment of tubo-ovarian abscess due to pelvic inflammatory disease.
Roberts W; Dockery JL
South Med J; 1984 Jul; 77(7):860-3. PubMed ID: 6740355
[TBL] [Abstract][Full Text] [Related]
12. Experience of Tubo-Ovarian Abscess: A Retrospective Clinical Analysis of 318 Patients in a Single Tertiary Center in Middle Turkey.
Inal ZO; Inal HA; Gorkem U
Surg Infect (Larchmt); 2018 Jan; 19(1):54-60. PubMed ID: 29148955
[TBL] [Abstract][Full Text] [Related]
13. Which treatment should we choose for tubo-ovarian abscesses? Results of an 8-year clinical training in a tertiary center.
Bestel A; Günkaya OS; Aldıkactioglu Talmac M; Ballica Y; Colak Yuksek S; Gedik Ozkose Z; Elmas B; Goksever Celik H
Ginekol Pol; 2024; 95(5):350-355. PubMed ID: 38099661
[TBL] [Abstract][Full Text] [Related]
14. Experience of tubo-ovarian abscess in western Turkey.
Güngördük K; Guzel E; Asicioğlu O; Yildirim G; Ataser G; Ark C; Gulova SS; Uzuncakmak C
Int J Gynaecol Obstet; 2014 Jan; 124(1):45-50. PubMed ID: 24139472
[TBL] [Abstract][Full Text] [Related]
15. The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience.
Demirtas O; Akman L; Demirtas GS; Hursitoglu BS; Yilmaz H
Arch Gynecol Obstet; 2013 Mar; 287(3):519-23. PubMed ID: 23104053
[TBL] [Abstract][Full Text] [Related]
16. Serum procalcitonin levels together with clinical features and inflammatory markers in women with tubo-ovarian abscess for discriminating requirements for surgery for full recovery.
Karaca K; Ozkaya E; Kurek Eken M; Uygun I; Kopuk SY; Alpay M
J Obstet Gynaecol; 2018 Aug; 38(6):818-821. PubMed ID: 29523046
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of the tubo-ovarian abscesses].
Garbin O; Verdon R; Fauconnier A
J Gynecol Obstet Biol Reprod (Paris); 2012 Dec; 41(8):875-85. PubMed ID: 23146745
[TBL] [Abstract][Full Text] [Related]
18. Clinical Predictors of Failed Medical Treatment in Patients with Tubo-ovarian Abscess: External Validation of a Recently Published Risk Score.
Jalloul RJ; Thomas M; Ward C; Pedroza C
J Minim Invasive Gynecol; 2022 May; 29(5):649-655. PubMed ID: 35051659
[TBL] [Abstract][Full Text] [Related]
19. Complicated Clinical Course and Poor Reproductive Outcomes of Women with Tubo-Ovarian Abscess after Fertility Treatments.
Fouks Y; Cohen Y; Tulandi T; Meiri A; Levin I; Almog B; Cohen A
J Minim Invasive Gynecol; 2019 Jan; 26(1):162-168. PubMed ID: 29890350
[TBL] [Abstract][Full Text] [Related]
20. The management of pelvic abscess.
Granberg S; Gjelland K; Ekerhovd E
Best Pract Res Clin Obstet Gynaecol; 2009 Oct; 23(5):667-78. PubMed ID: 19230781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
